Deep Learning with Contrast-Enhanced Ultrasound for Preoperative Prediction of Early Recurrence in Hepatocellular Carcinoma After Hepatectomy

深度学习结合对比增强超声用于肝切除术后肝细胞癌早期复发的术前预测

阅读:1

Abstract

BACKGROUND: Hepatectomy is the primary curative treatment for early-stage hepatocellular carcinoma (HCC). However, post-operative early recurrence remains a significant challenge. The existing predictive approaches based on clinicopathological features lack sufficient accuracy. This study aimed to develop a deep learning (DL) framework using contrast-enhanced ultrasound (CEUS) to preoperatively predict early recurrence in patients with HCC undergoing hepatectomy. PATIENTS AND METHODS: In this retrospective study, a total of 115 patients with early-stage HCC who underwent preoperative CEUS were randomly divided into training (n=75) and validation (n=40) cohorts. Four DL models (CEUS-AP, CEUS-PP, CEUS-LP, and CEUS-MP) were developed using single-phase and multiphase CEUS cines. The CEUS-MP model, which integrated the arterial, portal venous, and late phases, was further combined with the clinical variables to construct a nomogram. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), sensitivity, and specificity. RESULTS:  The CEUS-MP model demonstrated superior predictive performance, with AUCs of 0.922 and 0.840 in the training and validation cohorts, respectively, significantly outperforming single-phase models (all P < 0.05). The combined nomogram achieved AUCs of 0.945 and 0.871 in the training and validation cohorts, respectively, with a high sensitivity (88.9% and 83.0%, respectively) and specificity (98.1% and 82.5%, respectively). Decision curve analysis confirmed the nomogram's clinical utility for threshold probabilities >30%. Visualization maps highlighted heterogeneous enhancement patterns as the key predictive features. CONCLUSION:  The DL-based CEUS framework, particularly when integrated with clinical variables, provides a noninvasive and accurate tool for the preoperative prediction of early recurrence in patients with HCC undergoing hepatectomy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。